Synthesis process of omarigliptin

The invention discloses a method for preparing omarigliptin and a method for preparing an intermediate. In the method for preparing the key intermediate compound 4 of the omarigliptin, a weak acid with the pKa value of 3.5-5 is added, so that the generation of byproducts is effectively inhibited, th...

Full description

Saved in:
Bibliographic Details
Main Authors ZHONG QINGLIN, TANG XIAOLIN
Format Patent
LanguageChinese
English
Published 20.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention discloses a method for preparing omarigliptin and a method for preparing an intermediate. In the method for preparing the key intermediate compound 4 of the omarigliptin, a weak acid with the pKa value of 3.5-5 is added, so that the generation of byproducts is effectively inhibited, the yield of the intermediate compound 4 is very high, and finally, the yield of the omarigliptin is greatly improved. 本发明公开一种制备奥格列汀及中间体的方法。在制备奥格列汀关键中间体化合物4的方法中,加入pKa值为3.5~5之间的弱酸,有效抑制副产物的产生,使中间体化合物4的产率非常高,最终大大提高了奥格列汀的收率。
AbstractList The invention discloses a method for preparing omarigliptin and a method for preparing an intermediate. In the method for preparing the key intermediate compound 4 of the omarigliptin, a weak acid with the pKa value of 3.5-5 is added, so that the generation of byproducts is effectively inhibited, the yield of the intermediate compound 4 is very high, and finally, the yield of the omarigliptin is greatly improved. 本发明公开一种制备奥格列汀及中间体的方法。在制备奥格列汀关键中间体化合物4的方法中,加入pKa值为3.5~5之间的弱酸,有效抑制副产物的产生,使中间体化合物4的产率非常高,最终大大提高了奥格列汀的收率。
Author TANG XIAOLIN
ZHONG QINGLIN
Author_xml – fullname: ZHONG QINGLIN
– fullname: TANG XIAOLIN
BookMark eNrjYmDJy89L5WRQDK7MK8lILc4sVigoyk9OLS5WyE9TyM9NLMpMz8ksKMnM42FgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8c5-hoaG5pbGBuaGjsbEqAEAjbknzw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 奥格列汀的合成工艺
ExternalDocumentID CN111793071A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN111793071A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:40:18 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN111793071A3
Notes Application Number: CN202010644218
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201020&DB=EPODOC&CC=CN&NR=111793071A
ParticipantIDs epo_espacenet_CN111793071A
PublicationCentury 2000
PublicationDate 20201020
PublicationDateYYYYMMDD 2020-10-20
PublicationDate_xml – month: 10
  year: 2020
  text: 20201020
  day: 20
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies SICHUAN CHECO PHARMACEUTICAL TECHNOLOGY CO., LTD
RelatedCompanies_xml – name: SICHUAN CHECO PHARMACEUTICAL TECHNOLOGY CO., LTD
Score 3.4205222
Snippet The invention discloses a method for preparing omarigliptin and a method for preparing an intermediate. In the method for preparing the key intermediate...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title Synthesis process of omarigliptin
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201020&DB=EPODOC&locale=&CC=CN&NR=111793071A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTBMNDc1SzbSNUwxTtY1SbUw1U0yTzLTTTI0SDG1TDU2NQYfYOrrZ-YRauIVYRrBxJAF2wsDPie0HHw4IjBHJQPzewm4vC5ADGK5gNdWFusnZQKF8u3dQmxd1KC9Y9DUrpGBmouTrWuAv4u_s5qzs62zn5pfkK0h6OgzYHo2dGRmYAU2o81By79cw5xAu1IKkKsUN0EGtgCgaXklQgxMVRnCDJzOsJvXhBk4fKET3kAmNO8VizAoBlfmAVtrxZnFCgWQ1f0K-WkK-bnAzm56Dijn54kyKLq5hjh76ALtiod7LN7ZD-EsYzEGFmCHP1WCQcHcKNXMzDI1MTUpEbQPzTgp0TLJOMkS2FBKtUgyTraQZJDCbY4UPklpBi5QIIHKXiMDGQaWkqLSVFlgpVqSJAcODQC1kHqM
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTBMNDc1SzbSNUwxTtY1SbUw1U0yTzLTTTI0SDG1TDU2NQYfYOrrZ-YRauIVYRrBxJAF2wsDPie0HHw4IjBHJQPzewm4vC5ADGK5gNdWFusnZQKF8u3dQmxd1KC9Y9DUrpGBmouTrWuAv4u_s5qzs62zn5pfkK0h6OgzYHo2dGRmYAU2sS1A5-y7hjmBdqUUIFcpboIMbAFA0_JKhBiYqjKEGTidYTevCTNw-EInvIFMaN4rFmFQDK7MA7bWijOLFQogq_sV8tMU8nOBnd30HFDOzxNlUHRzDXH20AXaFQ_3WLyzH8JZxmIMLMAOf6oEg4K5UaqZmWVqYmpSImgfmnFSomWScZIlsKGUapFknGwhySCF2xwpfJLyDJweIb4-8T6eft7SDFygAAOVw0YGMgwsJUWlqbLACrYkSQ4cMgCckH18
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Synthesis+process+of+omarigliptin&rft.inventor=ZHONG+QINGLIN&rft.inventor=TANG+XIAOLIN&rft.date=2020-10-20&rft.externalDBID=A&rft.externalDocID=CN111793071A